Sanofi - 23 Apr 2025 SCHEDULE 13G/A Report for Innate Pharma SA Ordinary Shares, Euro 0.05 nominal value per share (IPHA)

Filing Manager
Sanofi
Reporting Manager
SANOFI
Security
Innate Pharma SA Ordinary Shares, Euro 0.05 nominal value per share
Symbol
IPHA
Shares outstanding
92,214,221 shares
Disclosed Ownership
8,345,387 shares
Ownership
9%
Form type
SCHEDULE 13G/A
Filing time
29 Apr 2025, 18:48:10 UTC
Date of event
23 Apr 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Sanofi disclosed 9% ownership in Innate Pharma SA Ordinary Shares, Euro 0.05 nominal value per share (IPHA) on 23 Apr 2025."

Quick Takeaways

  • Sanofi filed SCHEDULE 13G/A for Innate Pharma SA Ordinary Shares, Euro 0.05 nominal value per share (IPHA).
  • Disclosed ownership: 9%.
  • Date of event: 23 Apr 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 29 Apr 2025, 18:48.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
SANOFI 9% 8,345,387 8,345,387 0 /s/ Alexandra Roger Alexandra Roger, Head of Legal Corporate and Finance

Sponsored